Early postoperative magnetic resonance imaging following nonneoplastic cortical resection

Journal of Neurosurgery

Volumn 84, Issue 2, 1996, Pages 174-179

  Henegar, Martin M ^a   Moran, Christopher J ^a   Silbergeld, Daniel L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

brain neoplasm; magnetic resonance imaging

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN CORTEX; BRAIN TUMOR; CANCER GRADING; CANCER SURGERY; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; EPILEPSY; FEMALE; HUMAN; IMAGE ENHANCEMENT; LOBECTOMY; MALE; MINIMAL RESIDUAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

EID: 0030061294     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.84.2.0174     Document Type: Article

References (45)

1. Ahmadi J, Hinton DR, Segall HD, et al: Surgical implications of magnetic resonance-enhanced dura. Neurosurgery 35: 370-377, 1994
2. Albert FK, Forsting M, Sartor K, et al: Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34:45-61, 1994
3. Ammirati M, Vick N, Liao Y, et al: Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 21:201-206, 1987
4. Andreou J, George AE, Wise A, et al: CT prognostic criteria of survival after malignant glioma surgery. AJNR 4:488-490, 1983
5. Bashir R, Hochberg F, Oot R: Regrowth patterns of glioblastoma multiforme related to planning of interstitial brachytherapy radiation fields. Neurosurgery 23:27-30, 1988
6. Bronen RA, Sze G: Magnetic resonance imaging contrast agents: theory and application to the central nervous system. J Neurosurg 73:820-839, 1990
7. Burger PC, Heinz ER, Shibata T, et al: Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 68:698-704, 1988
8. Cairncross JG, Macdonald DR, Pexman JHW, et al: Steroid-induced CT changes in patients with recurrent malignant glioma. Neurology 38:724-726, 1988
9. Cairncross JG, Pexman JHW, Rathbone MP, et al: Postoperative contrast enhancement in patients with brain tumor. Ann Neurol 17:570-572, 1985
10. Ciric I, Ammirati M, Vick N, et al: Supratentorial gliomas: surgical considerations and immediate postoperative results. Gross total resection versus partial resection. Neurosurgery 21: 21-26, 1987
11. Crocker EF, Zimmerman RA, Phelps ME, et al: The effect of steroids on the extravascular distribution of radiographic contrast material and technetium pertechnetate in brain tumors as determined by computed tomography. Radiology 119: 471-474, 1976
12. DiChiro G, Brooks RA, Girton ME, et al: Sequential MR imaging studies of intracerebral hematomas in monkeys. AJNR 7:193-199, 1985
13. Dickman CA, Rekate HL, Bird CR, et al: Unenhanced and gadolinium-DTPA-enhanced MR imaging in postoperative evaluation in pediatric brain tumors. J Neurosurg 71:49-53, 1989
14. Elster AD, DiPersio DA: Cranial postoperative site: assessment with contrast-enhanced MR imaging. Radiology 174:93-98, 1990
15. Elster AD, Jackels SC, Allen NS, et al: Dyke Award. Europium-DTPA: a gadolinium analogue traceable by fluorescence microscopy. AJNR 10:1137-1144, 1989
16. Elster AD, Moody DM: Early cerebral infarction: gadopentetate dimeglumine enhancement. Neuroradiology 177: 627-632, 1990
17. Gado MH, Phelps ME, Coleman RE: An extravascular component of contrast enhancement in cranial computed tomography. Radiology 117:589-593, 1975
18. Hitchcock E, Sato F: Treatment of malignant gliomata. J Neurosurg 21:497-505, 1964
19. Hochberg FH, Pruitt A: Assumptions in the radiotherapy of glioblastoma. Neurology 30:907-911, 1980
20. Höllerhage HG, Zumkeller M, Becker M, et al: Influence of type and extent of surgery on early results and survival time in glioblastoma multiforme. Acta Neurochir 113:31-37, 1991
21. Jeffries BF, Kishore PRS, Singh KS, et al: Contrast enhancement in the postoperative brain. Radiology 139:409-413, 1981
22. Jelsma R, Bucy PC: Glioblastoma multiforme. Its treatment and some factors effecting survival. Arch Neurol 20:161-171, 1969
23. Kinsella TJ, Collins J, Rowland J, et al: Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme. J Clin Oncol 6:871-879, 1988
24. Lanzieri CF, Larkins M, Mancall A, et al: Cranial postoperative site: MR imaging appearance. AJNR 9:27-34, 1988
25. Laohaprasit V, Silbergeld DL, Ojemann GA, et al: Postoperative CT contrast enhancement following lobectomy for epilepsy. J Neurosurg 73:392-395, 1990
26. Meyding-Lamadé U, Forsting M, Albert F, et al: Accelerated methaemoglobin formation: potential pitfall in early postoperative MRI. Neuroradiology 35:178-180, 1993
27. Nazzaro JM, Neuwelt EA: The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 73:331-344, 1990
28. Newall J, Ransohoff J, Kaplan B: Glioblastoma in the older patient: how long a course of radiotherapy is necessary? J Neurooncol 6:325-327, 1988
29. Ojemann GA: Surgical therapy for medically intractable epilepsy. J Neurosurg 66:489-499, 1987
30. Penn RD, Walser R, Kurtz D, et al: Tumor volume, luxury perfusion, and regional blood volume changes in man visualized bv subtraction computerized tomography. J Neurol 44: 449-457, 1976
31. Roth JG, Elvidge AR: Glioblastoma multiforme: a clinical survey. J Neurosurg 17:736-750, 1960
32. Runge VM, Clanton JA, Price AC, et al: Dyke Award. Evaluation of contrast-enhanced MR imaging in a brain-abscess model. AJNR 6:139-147, 1985
33. Salcman M: Surgical decision-making for malignant brain tumors. Clin Neurosurg 35:285-313, 1987
34. Salcman M: Survival in glioblastoma: historical perspective. Neurosurgery 7:435-439, 1980
35. Salcman M, Levine H, Rao K: Value of sequential computed tomography in the multimodality treatment of glioblastoma multiforme. Neurosurgery 8:15-19, 1981
36. Scanlon PW, Taylor WF: Radiotherapy of intracranial astrocytomas: analysis of 417 cases treated from 1960 through 1969. Neurosurgery 5:301-308, 1979
37. Shapiro WR: Treatment of neuroectodermal brain tumors. Ann Neurol 12:231-237, 1982
38. Silbergeld DL, Ojemann GA: The tailored temporal lobectomy. Neurosurg Clin N Am 4:273-281, 1993
39. Sze G: New applications of MR contrast agents in neuroradiology. Neuroradiology 32:421-438, 1990
40. Vecht CJ, Avezaat CJJ, van Putten WLJ, et al: The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients. J Neurol Neurosurg Psychiatry 53:466-471, 1990
41. Vick NA, Ciric IS, Eller TW, et al: Reoperation for malignant astrocytoma. Neurology 39:430-432, 1989
42. Wakai S, Andoh Y, Ochiai C, et al: Postoperative contrast enhancement in brain tumors and intracerebral hematomas: CT study. J Comput Assist Tomogr 14:267-271, 1990
43. Weir B: The relative significance of factors affecting postoperative survival in astrocytomas, grades 3 and 4. J Neurosurg 38:448-452, 1973
44. Wood JR, Green SB, Shapiro WR: The prognostic importance of tumor size in malignant gliomas: a computed tomographic image study by the Brain Tumor Cooperative Group. J Clin Oncol 6:338-343, 1988
45. Zagzag D, Goldenberg M, Brem S: Angiogenesis and blood-brain barrier breakdown modulate CT contrast enhancement: an experimental study in a rabbit brain-tumor model. AJNR 10: 529-534, 1989